ROCHE RECEIVES FDA APPROVAL FOR COMPANION DIAGNOSTIC TESTS TO IDENTIFY PATIENTS WITH HER2-POSITIVE METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA ELIGIBLE FOR ZIIHERA

Reuters · 2d ago

Please log in to view news